1 Louis, D.N., Ohgaki, H., Wiestler, O.D. et al. Who classification of tumours of the central nervous system. 4th ed. International Agency for Research on Cancer (IARC), Lyon; 2007
2 Peris-Bonet, R., Martinez-Garcia, C., Lacour, B. et al. Childhood central nervous system tumours--incidence and survival in Europe (1978-1997): report from Automated Childhood Cancer Information System project. Eur J Cancer. 2006; 42: 2064-2080
3 Gilbertson, R.J. and Ellison, D.W. The origins of medulloblastoma subtypes. Annu Rev Pathol. 2008; 3: 341-365
4. Chang, C.H., Housepian, E.M., and Herbert, C. Jr. An operative staging system and a megavoltage radiotherapeutic technic for cerebellar medulloblastomas. Radiology. 1969; 93:1351-1359
5. Allen, J.C., Donahue, B., DaRosso, R., and Nirenberg, A. (1996) Hyperfractionated craniospinal radiotherapy and adjuvant chemotherapy for children with newly diagnosed medulloblastoma and other primitive neuroectodermal tumors. Int. J. Rad. Oncol. Biol. Phys. 36, 1155-1161.
6. Kuhl, J., Muller, H.L., Berthold, F., Kortmann, R.-D., Deinlein, F., Maab, E., Graf, N., Gnekow, A., Scheurlen, W., Gobel, U., Wolff, J.E.A., Bamberg, M., Kaatsch, P., Kleihues, P., Rating, D., Sorensen, N., and Wiestler, O.D. (1998) Preradiation chemotherapy of children and young adults with malignant brain tumors: Results of the German pilot trial HIT ‘88/’89. Klin. Padiatr. 210, 227-233.
7. Evans, A.E., Jenkin, R.D., Sposto, R., Ortega, J.A., Wilson, C.B., Wara, W., Ertel, I.J., Kramer, S., Chang, C.H., Leikin, S.L., and Hammond, G.D. (1990) The treatment of medulloblastoma: Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone. J. Neurosurg. 72, 572-582.
8. Tait, D.M., Thornton-Jones, H., Bloom, H.J., Lemerle, J., and Morris-Jones, P. (1990) Adjuvant chemotherapy for medulloblastoma: The rst multi-centre control trial of the International Society of Paediatric Oncology (SIOP I). Eur. J. Cancer 26, 464-469.
9. Packer, R.J., Sutton, L.N., Elterman, R., Lange, B., Goldwein, J., Nicholson, H.S., Mulne, L., Boyett, J., D’Angio, G., Wechsler-Jentzsch, K., Reaman, G., Cohen, B., Bruce, D.A., Rorke, L.B., Malloy, P., Ryan, J., LaFond, D., Evans, E., and Schut, L. (1994) Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy. J. Neurosurg. 81, 690-698.
10. Tomita T, Das L, Radkowski MA. (1990) Bone metastases of medulloblastoma in childhood; correlation with flow cytometric DNA analysis. J Neurooncol. 1990 Apr;8(2):113-20.
11. Tarbell NJ, Loeffler JS, Silver B, Lynch E, Lavally BL, Kupsky WJ, Scott RM, Sallan SE. (1991) The change in patterns of relapse in medulloblastoma. Cancer. 1991 Oct 1;68(7):1600-4.
12. Zeltzer PM, Boyett JM, Finlay JL, Albright AL, Rorke LB, Milstein JM, Allen JC, Stevens KR, Stanley P, Li H, Wisoff JH, Geyer JR, McGuire-Cullen P, Stehbens JA, Shurin SB, Packer RJ. (1999) Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study. J Clin Oncol. 1999 Mar;17(3):832-45.
13. Cohen BH, Packer RJ. (1996) Chemotherapy for medulloblastomas and primitive neuroectodermal tumors. J Neurooncol. 1996 Jul;29(1):55-68.
14. Duffner PK, Cohen ME. (1991) The long-term effects of central nervous system therapy on children with brain tumors. Neurol Clin. 1991 May;9(2):479-95.
15. Taylor M.D., Northcott P.A., Korshunov A. (2012) Molecular subgroups of medulloblastoma: the current consensus. Acta Neuropathol. Apr 2012; 123(4): 465-472.
16. Packer RJ, Rood BR, MacDonald TJ. (2003) Medulloblastoma: present concepts of stratification into risk groups. Pediatr Neurosurg. 2003 Jul;39(2):60-7.
17. McManamy CS, Lamont JM, Taylor RE, Cole M, Pearson AD, Clifford SC, Ellison DW; United Kingdom Children's Cancer Study Group (2003) Morphophenotypic variation predicts clinical behavior in childhood non-desmoplastic medulloblastomas. J Neuropathol Exp Neurol. 2003 Jun;62(6):627-32.